The United Kingdom is grappling with a concerning resurgence of measles, as global health authorities announce the disease’s re-establishment on British soil. Following a worrisome plateau in vaccination coverage and a spike in cases—totaling 3,681 this year—the World Health Organisation (WHO) has declared the UK no longer eliminated the highly contagious virus. This alarming trend highlights the urgent need for increased immunisation among children.
Decline in Vaccination Rates
For the period of 2021 to 2023, the UK proudly held the status of having eliminated measles. However, the landscape has drastically changed, with vaccination rates stagnating and a significant rise in cases. Dr. Vanessa Saliba, a consultant epidemiologist at the UK Health Security Agency (UKHSA), cautioned, “Infections can return quickly when childhood vaccine uptake falls. Measles elimination is only possible if all eligible children receive two doses of the MMRV vaccine before they start school. Older children and adults who have missed their vaccinations must also catch up.”
The latest statistics from the UKHSA reveal that in the 2024/25 period, only 91.9 per cent of five-year-olds had received their first dose of the MMR (measles, mumps, and rubella) vaccine. This figure has not changed from the previous year and marks the lowest rate since the 2010/11 period. Even more concerning, only 83.7 per cent had received both doses, a slight decline from 83.9 per cent, representing the lowest coverage since the 2009/10 season. The WHO recommends that at least 95 per cent of children be vaccinated to achieve herd immunity.
New Vaccination Initiatives
In January, health officials took a proactive step by introducing the MMRV vaccine, which extends protection against measles, mumps, rubella, and chickenpox. This initiative aims to bolster vaccination rates and facilitate the campaign for disease elimination. The National Health Service (NHS) is also enhancing accessibility to vaccinations, including scheduling the second MMRV dose at a new 18-month appointment.
Understanding Measles
Measles is notorious for its contagious nature, with each infected individual capable of transmitting the virus to between 12 and 18 others who lack immunity. The virus can linger in the air for up to two hours, making it easy for unprotected individuals to inhale. Symptoms typically manifest 7 to 14 days post-exposure and include a distinctive rash, fever, runny nose, cough, and conjunctivitis. The rash usually begins on the face or neck before spreading to the rest of the body.
Complications from measles are not uncommon, particularly in children, and can lead to ear infections, pneumonia, and even encephalitis—swelling of the brain. Pregnant women face increased risks as well, with potential consequences including preterm labour and stillbirth. A rare but severe brain condition, subacute sclerosing panencephalitis, can develop years after recovery from measles, often with fatal outcomes.
Why it Matters
The resurgence of measles in the UK serves as a stark reminder of the critical importance of vaccination. With the WHO’s alarming declaration, the health of future generations hangs in the balance. As misinformation surrounding vaccines continues to proliferate, it is imperative for parents and guardians to understand the risks associated with measles and the protective benefits of immunisation. Ensuring that all children are vaccinated is not just a personal decision; it is a community responsibility that can safeguard public health and prevent the return of preventable diseases.
